2017年知识产权论坛 | 2017 Intellectual Property Forum

by: Karen Wilcox

由张江发展促进会提供赞助 | Sponsored by
Shanghai Zhangjiang Hi-Tech Park Development

2017年,在特朗普新政府的管理之下,受到监管环境发生改变的影响,美国的商业环境也将发生重大的变化。这些管理变革将会对企业及其知识产权决策产生何种影响,这一问题将会在未来许多个月中充满变数。欢迎参与我们2017年知识产权论坛系列活动中的首次研讨会,与我们共同探讨不断变化的形势及其对知识产权产生的影响。| In 2017, the U.S. business climate could see significant changes as the regulatory environment shifts under the new Trump administration. How these regulatory changes will impact businesses and their intellectual property decisions will be in flux for many months to come. Please join us for our first seminar in our 2017 Intellectual Property Forum series as we discuss this ever changing landscape and its impact on intellectual property.

论坛举行时间:2017年4月13日 | April 13, 2017 Forum

1:30-2:00 p.m. 登记 | Registration

2:00-4:30 p.m. 活动 | Program

长荣桂冠酒店 | The Evergreen Laurel Hotel
上海浦东软件园祖冲之路1136号桂冠厅1号和2号 | Rooms Laurel 1 & Laurel 2, No.1136 Zuchongzhi Road, Shanghai Pudong Software Park

地铁2号线金科路站 | Subway Line 2 Jinke Road station

议程 | Agenda

摘要 | Keynote
关于美国知识产权的最新信息 | Update on Intellectual Property in the U.S. (睿凯 (Rui Kai) Kristopher Reed) – 睿凯 (Rui Kai) 先生是美国凯拓国际律师事务所专利诉讼团队的合伙人律师,将会探讨美国专利法方面最新的发展情况,以及这些发展对于在美国境内进行知识产权保护和实施可能会产生的影响。睿凯 (Rui Kai) 先生同时还将探讨可能出现的立法和法律变革,以及这些变革对特朗普政府管理下的知识产权可能产生何种影响。| Mr. Reed, a Partner in the Patent Litigation Team at Kilpatrick Townsend, will discuss the most recent developments in United States Patent Law, and the potential impact of those developments on intellectual property protection and enforcement in the United States. Mr. Reed will also discuss potential legislative and legal changes that may impact intellectual property rights under the Trump Administration.

分会讨论 | Breakout Sessions
美国专利法的发展趋势 | U.S. Patent Law Trends (古怀恩 Charles Gray, 沈飞 Fei Shen, 尹潞 Lu Yin) – 深入探究美国专利法的最新变革与发展趋势,以及针对这些变革与发展趋势调整自身专利实务的实践探讨。| An in-depth review of recent changes and trends in U.S. patent law and a practical discussion on adjusting your patent practice to account for these changes and trends.

医药尽职调查及橙皮书 | Pharmaceutical Due Diligence Investigations and the Orange Book (詹姆斯·伊斯比斯特 A. James Isbester, 吴爱莉药学博士 Alyson Wooten, PharmD) – 在这一分会讨论中,Isbester和Wooten博士将会重点讨论如何开展与美国医药制品相关的尽职调查,其中包括讨论是否需要对橙皮书所列专利(或者有可能成为橙皮书所列专利)进行深入的尽职调查。| In this breakout session, Mr. Isbester and Dr. Wooten will focus on how to conduct a due diligence investigation as it relates to pharmaceuticals in the U.S., including a discussion of the need of heightened due diligence of Orange Book-listed patents (or potential OB-listed patents).

届时将会提供同声传译服务。| Simultaneous translation services will be provided.

哪些人需要参加?| Who Should Attend
公司管理层与决策者、法律顾问、知识产权经理及专员、业务经理、专利代理人、专利工程师以及其他负责了解及管理专利诉讼和策略的人士。此次研讨会将对美国法律最近发生的与即将迎来的变化进行及时分析,所有与会人员都将从中获益。| CEOs and decision makers, in-house counsel, IP managers and staff, business managers, patent agents, patent engineers and others tasked with understanding and managing patent litigation and strategy will benefit from this timely analysis of recent and upcoming changes in U.S. law.

请于2017年4月7日前回复。| RSVP By April 7, 2017

更多相关信息,请发送电子邮件至 hchen@kilpatricktownsend.com 与 Holly Chen 联系。| For more information, please contact Holly Chen at hchen@kilpatricktownsend.com.

Share
DISCLAIMER

While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.

DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.

If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.

×